ChemoCentryx, Inc. (CCXI) financial statements (2022 and earlier)

Company profile

Business Address 835 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments264,492436,570172,786176,984127,291117,76471,278
Cash and cash equivalents49,97832,29739,17928,08840,02012,02412,823
Short-term investments214,514404,273133,607148,89687,271105,74058,455
Restricted cash and investments1,080      
Receivables43321762,05851,09030,205 
Inventory, net of allowances, customer advances and progress billings851      
Inventory851      
Other undisclosed current assets2,7114,9681,4002,3421,449722757
Total current assets:269,177441,570174,362181,384179,830148,69172,035
Noncurrent Assets
Operating lease, right-of-use asset24,80626,9111,704
Property, plant and equipment32,26925,1602,1541,5361,210905949
Long-term investments and receivables97,85623,80029,454 7,9295,9975,011
Long-term investments97,85623,80029,454 7,9295,9975,011
Other noncurrent assets1,5441,4581,409390359279160
Total noncurrent assets:156,47577,32934,7211,9269,4987,1816,120
TOTAL ASSETS:425,652518,899209,083183,310189,328155,87278,155
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities33,10432,66921,33813,9359,9759,3165,494
Accounts payable6,74612,8751,5329661,400671675
Accrued liabilities26,35819,79419,80612,9698,5758,6454,819
Deferred revenue10,99312,58737,742
Debt18,9206,302     
Deferred revenue and credits22,96229,019 
Other undisclosed current liabilities   50,461   
Total current liabilities:63,01751,55859,08064,39632,93738,3355,494
Noncurrent Liabilities
Long-term debt and lease obligation, including:51,54518,09919,78619,6894,676  
Long-term debt, excluding current maturities4,71518,09919,78619,689   
Operating lease, liability46,830  
Other undisclosed long-term debt and lease obligation    4,676  
Liabilities, other than long-term debt24,97032,50464,21738772,44867,648154
Deferred revenue and credits72,19767,547 
Deferred revenue24,77224,00063,095
Deferred income tax liabilities 7,546 
Other liabilities1989581,122387251101154
Other undisclosed noncurrent liabilities 31,125 84,100   
Total noncurrent liabilities:76,51581,72884,003104,17677,12467,648154
Total liabilities:139,532133,286143,083168,572110,061105,9835,648
Stockholders' equity
Stockholders' equity attributable to parent, including:286,120385,61366,00014,73879,26749,88972,507
Common stock70696051494844
Additional paid in capital903,646870,788495,624389,398368,553356,966339,615
Accumulated other comprehensive income (loss)(483)114318(198)(119)(50)(40)
Accumulated deficit(617,097)(485,342)(429,986)(374,497)(289,200)(307,059)(267,096)
Stockholders' equity note, subscriptions receivable(16)(16)(16)(16)(16)(16)
Other undisclosed stockholders' equity attributable to parent      (16)
Total stockholders' equity:286,120385,61366,00014,73879,26749,88972,507
TOTAL LIABILITIES AND EQUITY:425,652518,899209,083183,310189,328155,87278,155

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues32,22464,89136,12842,87582,49711,935 
Revenue, net82,49711,935 
Revenue from related parties29,09964,39235,95242,875
Cost of revenue(302)      
Gross profit:31,92264,89136,12842,87582,49711,935 
Operating expenses(161,841)(120,068)(94,431)(83,145)(66,004)(52,655)(47,689)
Operating income (loss):(129,919)(55,177)(58,303)(40,270)16,493(40,720)(47,689)
Nonoperating income (expense)(1,836)(179)2,8142,3041,366757384
Investment income, nonoperating8592,4644,9633,5281,370757384
Interest and debt expense(2,695)(2,643)(2,149)(1,224)(4)  
Income (loss) before gain (loss) on sale of properties:(134,450)(57,999)(57,638)(39,190)17,855(39,963)(47,305)
Other undisclosed net income2,6952,6432,1491,224   
Net income (loss):(131,755)(55,356)(55,489)(37,966)17,855(39,963)(47,305)
Other undisclosed net income attributable to parent    4  
Net income (loss) available to common stockholders, diluted:(131,755)(55,356)(55,489)(37,966)17,859(39,963)(47,305)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(131,755)(55,356)(55,489)(37,966)17,855(39,963)(47,305)
Comprehensive income (loss):(131,755)(55,356)(55,489)(37,966)17,855(39,963)(47,305)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(597)(204)516(79)(65)(10)30
Comprehensive income (loss), net of tax, attributable to parent:(132,352)(55,560)(54,973)(38,045)17,790(39,973)(47,275)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: